Literature DB >> 6115617

Psoriasis and human growth hormone: aetiology and therapy.

G Weber, G Klughardt, M Neidhardt.   

Abstract

First report on nine patients suffering from psoriasis who were treated with somatostatin or bromocriptin or both. These are inhibitors of HGH. The therapeutical effect on skin lesions and psoriatic alterations to joints is described.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6115617     DOI： 10.1007/bf00403941

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN： 0340-3696            Impact factor:   3.017


  4 in total

1.  Half-life of somatostatin-like immunoreactivity in canine plasma.

Authors:  V Schusdziarra; V Harris; R H Unger
Journal:  Endocrinology       Date:  1979-01       Impact factor: 4.736

Review 2.  [Somatostatin. Hormone of the nervous system and of the gastrointestinal tract with multiple effects].

Authors:  U Keller
Journal:  Ther Umsch       Date:  1979-10

3.  [Correlation of growth hormone and aetiology of psoriasis].

Authors:  G Weber; M Neidhardt; A Schmidt; A Geiger
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

4.  [Relationship between psoriasis and human growth hormone (author's transl)].

Authors:  G Weber; M Neidhardt
Journal:  MMW Munch Med Wochenschr       Date:  1980-11-21
  4 in total
  11 in total

Review 1.  The therapeutic value of somatostatin and its analogues.

Authors:  S Farooqi; J S Bevan; M C Sheppard; J A Wass
Journal:  Pituitary       Date:  1999-06       Impact factor: 4.107

2.  Absence of somatostatin receptors in psoriatic skin lesions.

Authors:  J C Reubi; T Hunziker
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

3.  Growth hormone levels in psoriasis.

Authors:  R M MacKie; G M Beastall; J A Thomson
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

4.  Somatostatin treatment of psoriasis.

Authors:  J J Guilhou; A Boulanger; G Barneon; P Vic; J Meynadier; J C Tardieu; J Clot
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

5.  Growth hormone producing hyperplasia of pituitary gland in psoriasis.

Authors:  G Weber; G Pliess; U Heitz
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

6.  Comments to the paper by Weber et al., Psoriasis and human growth hormone aetiology and therapy, Arch Dermatol Res (1981) 270: 361 - 365.

Authors:  J Köbberling; K von Werder
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

7.  Bromocriptine treatment of psoriasis.

Authors:  J J Guilhou; E Guilhou
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

8.  Treatment of psoriasis with bromocriptin.

Authors:  G Weber; M Neidhardt; H Frey; K Galle; A Geiger
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

9.  Treatment of psoriasis with somatostatin.

Authors:  G Weber; G Klughardt; M Neidhardt; K Galle; H Frey; A Geiger
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

10.  Growth hormone levels in psoriasis.

Authors:  G C Priestley; D J Gawkrodger; J Seth; S M Going; J A Hunter
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.